Recommendations for research

The guideline committee has made the following recommendations for research.

1 Clinical features for distinguishing between type 1 diabetes and other types of diabetes

What are the best clinical features or combination of features for distinguishing between type 1 diabetes and other types of diabetes? [2022]

For a short explanation of why the committee made the recommendation for research, see the rationale section on diagnosis.

Full details of the evidence and the committee's discussion are in evidence review C: diagnosis of diabetes.

2 The use of C-peptide in diagnosing diabetes

What is the effectiveness of C‑peptide at correcting misclassification of diabetes diagnosis and what is the optimal timing for the test in distinguishing subtypes of diabetes? [2022]

For a short explanation of why the committee made the recommendation for research, see the rationale section on diagnosis.

Full details of the evidence and the committee's discussion are in evidence review C: diagnosis of diabetes.

3 Use of routinely collected real-world data to examine the effectiveness and cost effectiveness of continuous glucose monitoring

Based on routinely collected real-world data, what is the effectiveness and cost effectiveness of continuous glucose monitoring (CGM) devices to improve glycaemic control? [2022]

For a short explanation of why the committee made the recommendation for research, see the rationale section on CGM.

Full details of the evidence and the committee's discussion are in evidence review A: continuous glucose monitoring in adults with type 1 diabetes.

  • National Institute for Health and Care Excellence (NICE)